Getting Investors' Pulses Beating Again
Getting Investors’ Pulses Beating Again
Any biotech slowdown will be temporary, says VC Nick Galakatos, who believes 2004′s ‘promising products’ will be a catalyst for the sector
Getting Investors’ Pulses Beating Again
Any biotech slowdown will be temporary, says VC Nick Galakatos, who believes 2004′s ‘promising products’ will be a catalyst for the sector
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Leave a Reply
Want to join the discussion?Feel free to contribute!